Continuous renewal ︱ only wish the world be free of disease

The medical enterprises consciously fulfill their social responsibilities and give full play to their responsibilities and missions at critical moments Recently, an article of "only wish the world to be free of disease -- Wuhan anti epidemic medicine enterprise donation honor list" by yaozhi.com has aroused resonance in the pharmaceutical industry In this silent smoke, in addition to the front-line fighting medical personnel, the "logistics support" of pharmaceutical enterprises has been continuously donated, funded, actively researched and developed, striving for the success of anti epidemic as soon as possible Now we update the sequel of "only wish the world to be free of disease - Wuhan anti epidemic medicine enterprise donation glorious list", fully identify in front of this battle, the pharmaceutical enterprises stand guard, adhere to the special, special position of the pharmaceutical enterprises! Novel coronavirus pneumonia medicine enterprise donation (second batch) Note: rank is not divided, if there is omission, welcome to continue to add message (the latest drug progress is attached to the table) it is worth noting that as the fight against the epidemic enters a critical moment, the fast-moving materials provided by pharmaceutical enterprises are no longer limited to the support of masks and cash, but are considered in all aspects From the donation details in the table above, it can be seen intuitively that most of the subsequent pharmaceutical enterprises are in urgent need of medical materials and drugs as the primary donation materials The novel coronavirus pneumonia, a leading pharmaceutical company, has donated over 3 million yuan of independent research and development drug, sulphur bemet sine, in order to reduce the frequency of medical treatment and risk of exposure to chemotherapy for patients with low immunity, and help prevent and control the epidemic Under the premise of ensuring the needs of the front line, corporate donation should truly achieve targeted participation in donation For novel coronavirus pneumonia, unremittingly, our pharmaceutical manufacturers actively develop and search for the best specific drugs and screen out effective drugs for prevention and suppression This is not in unremitting efforts A group of drugs talent shows itself: chemical drugs - old medicine, new chloroquine phosphate chloroquine phosphate is a antimalarial drug that has been on the market for more than 70 years As of February 19, more than ten hospitals are carrying out clinical research, with more than 100 patients enrolled Novel coronavirus phosphate clinical trial details: source of data: drug intelligence data In addition, today, the national health and Health Committee formally issued the new coronavirus pneumonia diagnosis and treatment plan (trial version sixth), and formally incorporated chloroquine phosphate into antiviral drugs According to the query of pharmaceutical intelligence data Enterprise Edition - China listed drug database, currently there are 52 listed chloroquine phosphate manufacturers in China, and 16 have applied for listing It is expected that chloroquine phosphate will play an unexpected role in the fight against the epidemic Radcivir, a broad-spectrum antiviral drug, has not been approved for marketing worldwide Gilead has officially said it has reached an agreement with China's health authorities to support two clinical trials for people infected with 2019-ncov to determine safety and effectiveness It also stated that the drug was supplied free of charge and provided support for the design and conduct of the study At a recent press conference, the Ministry of science and technology said: clinical research has been carried out in 11 hospitals in Wuhan, including 168 patients with severe disease and 17 patients with light common type We are looking forward to the results of clinical trials as soon as possible A novel coronavirus pneumonia trial was initiated in February 14th by the national infectious disease clinical medical research center and the third people's Hospital of Shenzhen According to the intelligence data, there are three applications for clinical application Recently, Haizheng fabiravir tablets have been approved for listing in China Abidol today, the sixth edition of the "diagnosis and treatment program," abidol will be included in the antiviral drugs Recently, pharmaceutical companies have taken action Ruikang pharmaceutical said that at present, the company has abidol on sale and has sufficient inventory; minoua and Nanjing Xiansheng Pharmaceutical Co., Ltd plan to jointly develop abidol hydrochloride and other antiviral APIs in the field of antiviral The novel coronavirus pneumonia has been directly applied in the Chinese medicine The major hospitals have begun to combine traditional Chinese medicine with the treatment of new crown pneumonia The corresponding enterprises have begun to help donors to give the most powerful logistic support The combination of Chinese and Western medicine has achieved good results "I attach great importance to the effect of traditional Chinese medicine on new coronavirus in the laboratory Once there is evidence, traditional Chinese medicine can be used safely, especially in the early and middle stages," said academician Zhong Nanshan For example, Lianhua Qingwen capsule (exclusive for Yiling), Xuebijing injection (exclusive for HongRi pharmaceutical industry), Tanreqing Injection (exclusive for Shanghai Kaibao) and other products have entered the clinical trial stage Novel coronavirus pneumonia was designated to be treated in Guangdong by the Guangdong drug administration in February 8th According to clinical need, the drug was directly used to relieve the pain of granule (pneumonia No 1) At present, the drug has been entrusted to Guangdong Yifang Pharmaceutical Co., Ltd for production and preparation In addition, in the sixth edition of the diagnosis and treatment plan, Fangfengtongsheng pills (granules) were removed Antibody plasma the plasma (from the convalescent patients of new crown) specially immunized with new crown virus prepared by China Bio Pharmaceutical Co., Ltd contains antibody against new crown virus At present, more than 10 critical patients have been treated with remarkable effect However, due to the need to cure the patient's plasma, it can not be widely used Academician Zhong Nanshan said that Guangdong will also adopt the plasma treatment method, and the plasma treatment method has little effect on the patients in danger due to organ failure Novel coronavirus pneumonia vaccine is China's vaccine Association In February 9th, the Chinese vaccine Association said that 17 member units are currently working on the development of the new crown pneumonia vaccine It is reported that at present, some vaccine varieties have entered the animal test stage, and the R & D progress basically keeps pace with the international progress With the help of enterprises, we can win this hard battle Come on, Wuhan! Come on, China! Data source: drug intelligence data, enterprise announcement and other online public data information sources: drug intelligence data, Beijing News, enterprise announcement and other online public information Mengmeng statement: this point of view only represents the author, not the position of drug intelligence network, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.